Press "Enter" to skip to content

Randomized Phase II Trial of Neoadjuvant Everolimus in Patients with High-risk Localized Prostate Cancer – Beyond the Abstract – UroToday

admin 0

Randomized Phase II Trial of Neoadjuvant Everolimus in Patients with High-risk Localized Prostate Cancer – Beyond the Abstract  UroToday

pathologic response following radical prostatectomy, localized prostate cancer with high-risk features, radiation therapy (RT), radical prostatectomy (RP), …

“prostate cancer” – Google News

(Visited 4 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *